FDA Inspection 1053273 — Martin G. Pomper, MD

Martin G. Pomper, MD — FEI 3014321667

The FDA completed an inspection of Martin G. Pomper, MD on May 25, 2018 in Baltimore, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
May 25, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Baltimore, MD (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance